Methylglyoxal‐infused honey mimics the anti‐Staphylococcus aureus biofilm activity of manuka honey: Potential Implication in Chronic Rhinosinusitis
- 25 April 2011
- journal article
- sinonasal
- Published by Wiley in The Laryngoscope
- Vol. 121 (5), 1104-1107
- https://doi.org/10.1002/lary.21717
Abstract
Objectives/Hypothesis: Low pH, hydrogen peroxide generation, and the hyperosmolarity mechanisms of antimicrobial action are ubiquitous for all honeys. In addition, manuka honey has been shown to contain high concentrations of methylglyoxal (MGO), contributing the relatively superior antimicrobial activity of manuka honey compared to non‐MGO honeys. In high concentrations, manuka honey is effective in killing Staphylococcus aureus biofilms in vitro. Lower concentrations of honey, however, are desirable for clinical use as a topical rinse in chronic rhinosinusitis in order to maximize the tolerability and practicality of the delivery technique. This study, therefore, was designed to evaluate the contribution of MGO to the biofilm‐cidal activity of manuka honey, and furthermore determine whether the antibiofilm activity of low‐dose honey can be augmented by the addition of exogenous MGO. Study Design: In vitro microbiology experiment. Methods: Five S. aureus strains (four clinical isolates and one reference strain) were incubated to form biofilms using a previously established in vitro dynamic peg model. First, the biofilm‐cidal activities of 1) manuka honey (790 mg/kg MGO), 2) non‐MGO honey supplemented with 790 mg/kg MGO, and 3) MGO‐only solutions were assessed. Second, the experiment was repeated using honey solutions supplemented with sufficient MGO to achieve concentrations exceeding those seen in commercially available manuka honey preparations. Results: All honey solutions containing a MGO concentration of 0.53 mg/mL or greater demonstrated biofilm‐cidal activity; equivalent activity was achieved with ≥1.05 mg/mL MGO solution. Conclusions: MGO is only partially responsible for the antibiofilm activity of manuka honey. Infusion of MGO‐negative honey with MGO, however, achieves similar cidality to the equivalent MGO‐rich manuka honey.Keywords
This publication has 22 references indexed in Scilit:
- Preventing Surgical-Site Infections in Nasal Carriers ofStaphylococcus aureusThe New England Journal of Medicine, 2010
- Targeted imaging modality selection for bacterial biofilms in chronic rhinosinusitisThe Laryngoscope, 2009
- The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- The Efficacy of Topical Antibiofilm Agents in a Sheep Model of RhinosinusitisAmerican Journal of Rhinology, 2008
- In Vitro Activity of Mupirocin on Clinical Isolates of Staphylococcus aureus and its Potential Implications in Chronic RhinosinusitisThe Laryngoscope, 2008
- Effectiveness of Topical Antibiotics on Staphylococcus Aureus Biofilm in VitroAmerican Journal of Rhinology, 2007
- Staphylococcus aureusNasal Carriage in a Student Community Prevalence, Clonal Relationships, and Risk FactorsInfection Control & Hospital Epidemiology, 2004
- Protective mechanisms against toxic electrophiles in Escherichia coliTrends in Microbiology, 1999
- A Survey of the Antibacterial Activity of Some New Zealand HoneysJournal of Pharmacy and Pharmacology, 1991
- The Effect of Methyl Glyoxal on Cell Division and the Synthesis of Protein and DNA in Synchronous and Asynchronous Cultures of Escherichia coli B/rMicrobiology, 1980